J. C 700 ( 1992. ). [PubMed] [Google Scholar] 24. ) Slamon , D. J. , Godolphin , W. , Jones , L. A. , Holt , J. A. , Wong , S. G. , Keith , D. E. , Levin , W. J. , Stuart , S. G. , Udove , J. , Ullrich , A. and Press , M. F.Research from the HER2/protooncogene in individual ovarian and breasts cancer tumor . Research , 244 , 707 C 712 ( 1989. ). [PubMed] [Google Scholar] 25. ) Rolitsky , C. D. , Theil , K. S. , McGaughy , V. R. , Copeland , L. J. and Niemann , T. H.Overexpression and HER2/amplification in endometrial carcinoma . Int. J. Gynecol. Pathol. , 18 , 138 GABPB2 C 143 ( 1999. ). [PubMed] [Google Scholar] 26. ) Kern , J. A. , Schwartz , D. A. , Nordberg , J. E. , Weiner , D. B. , Greene , M. I. , Torney , L. and Robinson , R. A.P185expression in individual lung adenocarcinomas predicts shortened success . Cancer tumor Res. , 50 , 5184 C 5187 ( 1990. ). [PubMed] [Google Scholar] 27. ) Jaehne , J. , Urmacher , C. , Thaler , H. T. , Friedlander\Klar , H. , Cordon\Cardo , C. and Meyer , H. J.Appearance of oncogene item p185 in relationship to clinico\pathological and prognostic elements of gastric carcinoma . J. Cancers Res. Clin. Oncol. , 118 , 474 C 479 ( 1992. ). [PubMed] [Google Scholar] 28. ) D’Emilia , J. , Bulovas , K. , D’Ercole , K. , Wolf , B. , Steele , G. and Summerhayes , I. C.Appearance from the c\erbB\2 gene item Alcaftadine (p185) in different levels of neoplastic development in the digestive tract . Oncogene , 4 , 1233 C 1239 ( 1989. ). [PubMed] [Google Scholar] 29. ) Al\Kasspooles , M. , Moore , J. H. , Orringer , M. B. and Beverage , D. G.More than\appearance and Amplification from the ECFR and serbB\2 genes in individual esophageal adenocarcinomas . Alcaftadine Int. J. Cancers , 54 , 213 C 219 ( 1993. ). [PubMed] [Google Scholar] 30. ) Neal , D. E. , Marsh , C. , Bennett , M. K. , Abel , P. D. , Hall , R. R. , Sainsbury , J. R. and Harris , A. L.Epidermal\development\aspect receptors in individual bladder cancers: evaluation of invasive and superficial tumors . Lancet , i , 366 C 368 ( 1985. ). [PubMed] [Google Scholar] 31. ) Lei , S. , Appert , H. E. , Nakata , B. , Domenico , D. R. , Kim , K. and Howard , J. M.Overexpression of HER2/oncogene in pancreatic cancers correlates with shortened surival . Int. J. Pancreatol. , 17 , 15 C 21 ( 1995. ). [PubMed] [Google Scholar] 32. ) Seki , A. Alcaftadine , Yoshinouchi , M. , Seki , N. , Kodama , J. , Miyagi , Y. and Kudo , T.Recognition of c\erbB\2 and FGF\3 (INT\2) gene amplification in epithelial ovarian cancers . Int. J. Oncol. , 17 , 103 C 106 ( 2000. ). [PubMed] [Google Scholar] 33. ) Afify , Alcaftadine A. M. , Werness , B. A. and Tag , H. F.HER\2/neu oncogene amplification in stage We and stage III ovarian papillary serous carcinoma . Exp. Mol. Pathol. , 66 , 163 C 169 ( 1999. ). [PubMed] [Google Scholar] 34. ) Kim , Y. T. , Kim , J. W. and Lee , J. W.c\erbB\2 oncoprotein assay in ovarian carcinoma and its own clinical relationship with prognostic elements . Cancer tumor Lett. , 132 , 91 C 97 ( 1998. ). [PubMed] [Google Scholar] 35. ) Rolitsky , C. D. , Theil , K. S. , McGaughy , V. R. , Copeland , L. J. and Niemann , T. H.HER\2/neu overexpression and amplification in endometrial carcinoma . Int. J. Gynecol. Pathol. , 18 , 138 C 143 ( 1999. ). [PubMed] [Google Scholar] 36. ) Leitzel , K. , Teramoto , Y. , Konrad , K. , Chinchilli , V. M. , Volas , G. , Grossberg , H. , Harvey , H. , Demers , L. and Lipton , A.Raised serum c\erbB\2 antigen levels and reduced response to hormone therapy of breast cancer . J. Clin. Oncol. , 13 , 1129 C 1135 ( 1995. ). Alcaftadine [PubMed] [Google Scholar] 37. ) Berns , E. M. , Foekens , J. A. , truck Staveren , I. L. , truck Putten.